Hanley stated that Nexsen has partnered with Atomo Diagnostics to manufacture the first 10,000 units of StrepSure, which will be used as part of the clinical trial. However, the company plans to seek third-party manufacturing and plans to control marketing distribution internally.
That's the kicker only a test wow. AT1 won't be the manufacture in the future. Test only.
AT1 FY21 - General Discussion + FA, page-2432
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.002(7.14%) |
Mkt cap ! $19.17M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.7¢ | $26.80K | 950.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47862 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 186340 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.9¢ | 2.9¢ | 2.7¢ | 333390 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| AT1 (ASX) Chart |